Skip to menu Skip to content Skip to footer

2011

Conference Publication

Regulation of Renal Receptor for Advanced Glycation End Products (Rage) Via Paracrine Estrogens

Harcourt, B. E., Coughlan, M. T., Andrikopoulos, S., Thomas, M. C., Bruce, C., Febbraio, M. A., Nawroth, P., Bierhaus, A., Kantharidis, P., Cooper, M. E. and Forbes, J. M. (2011). Regulation of Renal Receptor for Advanced Glycation End Products (Rage) Via Paracrine Estrogens. WILEY-BLACKWELL.

Regulation of Renal Receptor for Advanced Glycation End Products (Rage) Via Paracrine Estrogens

2011

Conference Publication

Ubiquinone Is Renoprotective in An Experimental Model of Type 2 Diabetes

Sourris, K. C., Morley, A. L., Harcourt, B. E., Penfold, S. A., Coughlan, M. T., Nugyen, T-V, Cooper, M. E., Ritchie, R. H. and Forbes, J. M. (2011). Ubiquinone Is Renoprotective in An Experimental Model of Type 2 Diabetes. WILEY-BLACKWELL.

Ubiquinone Is Renoprotective in An Experimental Model of Type 2 Diabetes

2011

Conference Publication

Detrimental Effects of Dietary Advanced Glycation End Products on Insulin Sensitivity in Healthy Overweight Individuals

De Courten, Barbora, De Courten, Maximilian, Walker, Karen, Staznicky, Nora, Sourris, Karly, Dougherty, Sonia, Schlaich, Markus, Soldatos, Georgia and Forbes, Josephine (2011). Detrimental Effects of Dietary Advanced Glycation End Products on Insulin Sensitivity in Healthy Overweight Individuals. ALEXANDRIA: AMER DIABETES ASSOC.

Detrimental Effects of Dietary Advanced Glycation End Products on Insulin Sensitivity in Healthy Overweight Individuals

2010

Conference Publication

The renin-angiotensin system and advanced glycation end-products in diabetic nephropathy how important are these pathways as therapeutic targets?

Sourris, K. C. and Forbes, J. M. (2010). The renin-angiotensin system and advanced glycation end-products in diabetic nephropathy how important are these pathways as therapeutic targets?. Royal Society of Chemistry.

The renin-angiotensin system and advanced glycation end-products in diabetic nephropathy how important are these pathways as therapeutic targets?

2010

Conference Publication

The pathogenic potential of different sized age modified molecules via rage signalling pathways

Penfold, S. A., Sourris, K. C., Coughlan, M. T., Tan, A. L., Kaye, D. M., Cooper, M. E. and Forbes, J. M. (2010). The pathogenic potential of different sized age modified molecules via rage signalling pathways. International Symposium on the The Maillard Reaction, Palm Cove, QLD, Australia, 29-31 August 2009. Cambridge, United Kingdom: Royal Society of Chemistry.

The pathogenic potential of different sized age modified molecules via rage signalling pathways

2009

Conference Publication

High Density Lipoprotein Modulates Glucose Metabolism by Multiple Mechanisms

Drew, Brian G., Duffy, Stephen J., Forbes, Josephine M., Chin-Dusting, Jaye, Kaye, David M., Kemp, Bruce E., Sviridov, Dmitri, Steinberg, Gregory R. and Kingwell, Bronwyn A. (2009). High Density Lipoprotein Modulates Glucose Metabolism by Multiple Mechanisms. 82nd Scientific Session of the American-Heart-Association, Orlando Fl, Nov 14-18, 2009. LIPPINCOTT WILLIAMS & WILKINS.

High Density Lipoprotein Modulates Glucose Metabolism by Multiple Mechanisms

2009

Conference Publication

Plasma Hepatocyte Growth Factor (HGF) Is Inversely Associated with Insulin Sensitivity in Healthy Humans

De Courten, Barbora, De Courten, Maximilian P. J., Dougherty, Sonia, Woollard, Kevin J., Cooper, Mark E., Kingwell, Bronwyn A., Forbes, Josephine M., Potts, Jenna R. and Considine, Robert V. (2009). Plasma Hepatocyte Growth Factor (HGF) Is Inversely Associated with Insulin Sensitivity in Healthy Humans. 69th Annual Meeting of the American-Diabetes-Association, New Orleans La, Jun 05-09, 2009. AMER DIABETES ASSOC.

Plasma Hepatocyte Growth Factor (HGF) Is Inversely Associated with Insulin Sensitivity in Healthy Humans

2008

Conference Publication

Interaction between the renin-angiotensin system (RAS) and advanced glycation end products (AGES) in the development of diabetic nephropathy

Sourris, K. C., Mibus, A. L., Koitka, A., Harcourt, B. E., Tan, A. L. Y., Cooper, M. E. and Forbes, J. M. (2008). Interaction between the renin-angiotensin system (RAS) and advanced glycation end products (AGES) in the development of diabetic nephropathy. SPRINGER.

Interaction between the renin-angiotensin system (RAS) and advanced glycation end products (AGES) in the development of diabetic nephropathy

2008

Conference Publication

The renal pathogenicity of dietary glycotoxins is mediated via the receptor for advanced glycation end products (RAGE)

Coughlan, Melinda T., Mibus, Amy L., Tan, Adeline L., Harcourt, Brooke E., Sourris, Karly C., Penfold, Sally A., Thallas-Bonke, Vicki, Yap, Felicia Y., Gasser, Anna, Thomas, Merlin, Su, Qing, Bierhaus, Angelika, Cooper, Mark E. and Forbes, Josephine M. (2008). The renal pathogenicity of dietary glycotoxins is mediated via the receptor for advanced glycation end products (RAGE). 67th Annual Meeting of the American-Diabetes-Association, San Francicso Ca, Jun 06-10, 2008. AMER DIABETES ASSOC.

The renal pathogenicity of dietary glycotoxins is mediated via the receptor for advanced glycation end products (RAGE)

2008

Conference Publication

Urinary, but not serum levels of the AGE, n-carboxymethyl-lysine are associated with progressive nephropathy in patients with type 1 and type 2 diabetes

Coughlan, Melinda T., Penfold, Sally A., Cooper, Mark E., Panagiotopoulos, Sianna, Macisaac, Richard J., Jerums, George and Forbes, Josephine M. (2008). Urinary, but not serum levels of the AGE, n-carboxymethyl-lysine are associated with progressive nephropathy in patients with type 1 and type 2 diabetes. 67th Annual Meeting of the American-Diabetes-Association, San Francicso Ca, Jun 06-10, 2008. AMER DIABETES ASSOC.

Urinary, but not serum levels of the AGE, n-carboxymethyl-lysine are associated with progressive nephropathy in patients with type 1 and type 2 diabetes

2008

Conference Publication

Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome?

Sourris, Karly C., Forbes, Josephine M. and Cooper, Mark E. (2008). Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome?. The 9th International Symposium on the Maillard Reaction, Munich, Germany, 1-5 September 2007. Malden, MA, United States: Wiley-Blackwell Publishing. doi: 10.1196/annals.1433.048

Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome?

2008

Conference Publication

Oxidative stress and advanced glycation in diabetic nephropathy

Coughlan, Melinda T., Mibus, Amy L. and Forbes, Josephine M. (2008). Oxidative stress and advanced glycation in diabetic nephropathy. The 9th International Symposium on the Maillard Reaction, Munich, Germany, 1-5 September 2007. Malden, MA, United States: Wiley-Blackwell Publishing. doi: 10.1196/annals.1433.018

Oxidative stress and advanced glycation in diabetic nephropathy

2007

Conference Publication

Interaction between the receptor for advanced glycation end products (RAGE) and estrone (E1) in the development of type 2 diabetic nephropathy

Harcourt, B. E., Mibus, A., Gasser, A., Andikopoulos, S., Thomas, M., Coughlan, M. T., Sourris, K., Rice, G., Bierhaus, A., Cooper, M. E. and Forbes, J. M. (2007). Interaction between the receptor for advanced glycation end products (RAGE) and estrone (E1) in the development of type 2 diabetic nephropathy. 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam Netherlands, Sep 18-21, 2007. SPRINGER.

Interaction between the receptor for advanced glycation end products (RAGE) and estrone (E1) in the development of type 2 diabetic nephropathy

2007

Conference Publication

Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes

Coughlan, M. T., Forbes, J. M. and Cooper, M. E. (2007). Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes. 5th Hyonam-Kidney-Laboratory-International-Diabetes Symposium, Seoul South Korea, Feb 02-03, 2007. Nature Publishing Group. doi: 10.1038/sj.ki.5002387

Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes

2006

Conference Publication

Diabetes-induced effects on endothelial function and the actions of nitric oxide

Soro-Paavonen, A., Zhang, W. -Z., Venardos, K., Jones, E., Chin-Dusting, J., Thomas, M. T., Coughlan, M. T., Brasacchio, D., Cooper, M. E., Kaye, D. and Forbes, J. M. (2006). Diabetes-induced effects on endothelial function and the actions of nitric oxide. 42nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Copenhagen Denmark, Sep 14-17, 2006. SPRINGER.

Diabetes-induced effects on endothelial function and the actions of nitric oxide

2005

Conference Publication

Advanced glycation end products and diabetic nephropathy

Thomas, Merlin C., Forbes, Josephine M. and Cooper, Mark E. (2005). Advanced glycation end products and diabetic nephropathy. doi: 10.1097/01.mjt.0000178769.52610.69

Advanced glycation end products and diabetic nephropathy

2005

Conference Publication

Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists

Cooper, ME, Forbes, JM, Smith, CM, Lassila, M, Jandeleit-Dahm, KA, Allen, TJ and Calkin, AC (2005). Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.

Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists

2005

Conference Publication

Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?

Thomas, Merlin C., Forbes, Josephine M., MacIsaac, Richard, Jerums, George and Cooper, Mark E. (2005). Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?. New York Academy of Sciences. doi: 10.1196/annals.1333.073

Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?

2005

Conference Publication

Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes

Coughlan, MT, Thorburn, DR, Fukami, K, Laskowski, A, Thallas-Bonke, V, Long, DM, Brownlee, M, Cooper, ME and Forbes, JM (2005). Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.

Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes

2005

Conference Publication

Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?

Forbes, JM, Coughlan, MT, Fukami, K, Laskowski, A, Thallas-Bonke, V, Dinh, D, Long, DM, Brownlee, M, Cooper, ME and Thorburn, DR (2005). Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.

Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?